Previous Article | Next Article 
J Virol, April 1998, p. 2945-2954, Vol. 72, No. 4
0022-538X/98/$04.00+0
Copyright © 1998, American Society for Microbiology. All rights reserved.
Cytotoxic T-Lymphocyte Target Proteins and Their
Major Histocompatibility Complex Class I Restriction in Response to
Adenovirus Vectors Delivered to Mouse Liver
Karin
Jooss,
Hildegund
C. J.
Ertl, and
James M.
Wilson*
Institute for Human Gene Therapy and
Department of Molecular and Cellular Engineering, University of
Pennsylvania, and Wistar Institute, Philadelphia, Pennsylvania 19104
Received 19 November 1997/Accepted 23 December 1997
The activation of cytotoxic T lymphocytes (CTLs) to cells infected
with adenovirus vectors contributes to problems of inflammation and
transient gene expression that attend their use in gene therapy. The
goal of this study was to identify in a murine model of liver gene
therapy the proteins that provide targets to CTLs and to characterize
the major histocompatibility complex (MHC) class I restricting
elements. Mice of different MHC haplotypes were infected with an
E1-deleted adenovirus expressing human alkaline phosphatase (ALP) or
-galactosidase as a reporter protein, and splenocytes were harvested
for in vitro CTL assays to aid in the characterization of CTL epitopes.
A library of vaccinia viruses was created to express individual viral
open reading frames, as well as the ALP and lacZ
transgenes. The MHC haplotype had a dramatic impact on the distribution
of CTL targets: in C57BL/6 mice, the hexon protein presented by both
H-2Kb and H2Db was dominant, and in C3H mice,
H-2Dk-restricted presentation of ALP was dominant. Adoptive
transfer of CTLs specific for various adenovirus proteins or transgene products into either Rag-I or C3H-scid mice infected previously with an
E1-deleted adenovirus verified the in vivo relevance of the
adenovirus-specific CTL targets identified in vitro. The results of
these experiments illustrate the impact of lr gene control on the
response to gene therapy with adenovirus vectors and suggest that the
efficacy of therapy with adenovirus vectors may exhibit considerable
heterogeneity when applied in human populations.
*
Corresponding author. Mailing address: 204 Wistar
Institute, 3601 Spruce St., Philadelphia, PA 19104-4268. Phone: (215)
898-3000. Fax: (215) 898-6588.
This article has been cited by other articles:
-
Joshi, A., Tang, J., Kuzma, M., Wagner, J., Mookerjee, B., Filicko, J., Carabasi, M., Flomenberg, N., Flomenberg, P.
(2009). Adenovirus DNA polymerase is recognized by human CD8+ T cells. J. Gen. Virol.
90: 84-94
[Abstract]
[Full Text]
-
Krause, A., Joh, J. H., Hackett, N. R., Roelvink, P. W., Bruder, J. T., Wickham, T. J., Kovesdi, I., Crystal, R. G., Worgall, S.
(2006). Epitopes expressed in different adenovirus capsid proteins induce different levels of epitope-specific immunity.. J. Virol.
80: 5523-5530
[Abstract]
[Full Text]
-
Li, X.-P., Li, C. Y.S., Li, X., Ding, Y., Chan, L. L.Y., Yang, P.-H., Li, G., Liu, X., Lin, J. S., Wang, J., He, M., Kung, H.-f., Lin, M. C., Peng, Y.
(2006). Inhibition of human nasopharyngeal carcinoma growth and metastasis in mice by adenovirus-associated virus-mediated expression of human endostatin. Molecular Cancer Therapeutics
5: 1290-1298
[Abstract]
[Full Text]
-
Dobrzynski, E., Fitzgerald, J. C., Cao, O., Mingozzi, F., Wang, L., Herzog, R. W.
(2006). Prevention of cytotoxic T lymphocyte responses to factor IX-expressing hepatocytes by gene transfer-induced regulatory T cells. Proc. Natl. Acad. Sci. USA
103: 4592-4597
[Abstract]
[Full Text]
-
Park, J. M., Terabe, M., Sakai, Y., Munasinghe, J., Forni, G., Morris, J. C., Berzofsky, J. A.
(2005). Early Role of CD4+ Th1 Cells and Antibodies in HER-2 Adenovirus Vaccine Protection against Autochthonous Mammary Carcinomas. J. Immunol.
174: 4228-4236
[Abstract]
[Full Text]
-
Muruve, D. A., Cotter, M. J., Zaiss, A. K., White, L. R., Liu, Q., Chan, T., Clark, S. A., Ross, P. J., Meulenbroek, R. A., Maelandsmo, G. M., Parks, R. J.
(2004). Helper-Dependent Adenovirus Vectors Elicit Intact Innate but Attenuated Adaptive Host Immune Responses In Vivo. J. Virol.
78: 5966-5972
[Abstract]
[Full Text]
-
Sumida, S. M., Truitt, D. M., Kishko, M. G., Arthur, J. C., Jackson, S. S., Gorgone, D. A., Lifton, M. A., Koudstaal, W., Pau, M. G., Kostense, S., Havenga, M. J. E., Goudsmit, J., Letvin, N. L., Barouch, D. H.
(2004). Neutralizing Antibodies and CD8+ T Lymphocytes both Contribute to Immunity to Adenovirus Serotype 5 Vaccine Vectors. J. Virol.
78: 2666-2673
[Abstract]
[Full Text]
-
Yang, T. C., Dayball, K., Wan, Y. H., Bramson, J.
(2003). Detailed Analysis of the CD8+ T-Cell Response following Adenovirus Vaccination. J. Virol.
77: 13407-13411
[Abstract]
[Full Text]
-
Wiethe, C., Dittmar, K., Doan, T., Lindenmaier, W., Tindle, R.
(2003). Provision of 4-1BB Ligand Enhances Effector and Memory CTL Responses Generated by Immunization with Dendritic Cells Expressing a Human Tumor-Associated Antigen. J. Immunol.
170: 2912-2922
[Abstract]
[Full Text]
-
Varnavski, A. N., Zhang, Y., Schnell, M., Tazelaar, J., Louboutin, J.-P., Yu, Q.-C., Bagg, A., Gao, G.-p., Wilson, J. M.
(2002). Preexisting Immunity to Adenovirus in Rhesus Monkeys Fails To Prevent Vector-Induced Toxicity. J. Virol.
76: 5711-5719
[Abstract]
[Full Text]
-
Thomas, C. E., Edwards, P., Wickham, T. J., Castro, M. G., Lowenstein, P. R.
(2002). Adenovirus Binding to the Coxsackievirus and Adenovirus Receptor or Integrins Is Not Required To Elicit Brain Inflammation but Is Necessary To Transduce Specific Neural Cell Types. J. Virol.
76: 3452-3460
[Abstract]
[Full Text]
-
Mercier, S., Gahery-Segard, H., Monteil, M., Lengagne, R., Guillet, J.-G., Eloit, M., Denesvre, C.
(2002). Distinct Roles of Adenovirus Vector-Transduced Dendritic Cells, Myoblasts, and Endothelial Cells in Mediating an Immune Response against a Transgene Product. J. Virol.
76: 2899-2911
[Abstract]
[Full Text]
-
Molinier-Frenkel, V., Lengagne, R., Gaden, F., Hong, S.-S., Choppin, J., Gahery-Segard, H., Boulanger, P., Guillet, J.-G.
(2002). Adenovirus Hexon Protein Is a Potent Adjuvant for Activation of a Cellular Immune Response. J. Virol.
76: 127-135
[Abstract]
[Full Text]
-
Sun, J., Bodola, F., Fan, X., Irshad, H., Soong, L., Lemon, S. M., Chan, T.-S.
(2001). Hepatitis C Virus Core and Envelope Proteins Do Not Suppress the Host's Ability To Clear a Hepatic Viral Infection. J. Virol.
75: 11992-11998
[Abstract]
[Full Text]
-
Zoltick, P. W., Chirmule, N., Schnell, M. A., Gao, G.-P., Hughes, J. V., Wilson, J. M.
(2001). Biology of E1-Deleted Adenovirus Vectors in Nonhuman Primate Muscle. J. Virol.
75: 5222-5229
[Abstract]
[Full Text]
-
Croyle, M. A., Chirmule, N., Zhang, Y., Wilson, J. M.
(2001). "Stealth" Adenoviruses Blunt Cell-Mediated and Humoral Immune Responses against the Virus and Allow for Significant Gene Expression upon Readministration in the Lung. J. Virol.
75: 4792-4801
[Abstract]
[Full Text]
-
Liu, Z.-X., Govindarajan, S., Okamoto, S., Dennert, G.
(2001). Fas-Mediated Apoptosis Causes Elimination of Virus-Specific Cytotoxic T Cells in the Virus-Infected Liver. J. Immunol.
166: 3035-3041
[Abstract]
[Full Text]
-
Sarukhan, A., Camugli, S., Gjata, B., von Boehmer, H., Danos, O., Jooss, K.
(2001). Successful Interference with Cellular Immune Responses to Immunogenic Proteins Encoded by Recombinant Viral Vectors. J. Virol.
75: 269-277
[Abstract]
[Full Text]
-
Russell, W. C.
(2000). Update on adenovirus and its vectors. J. Gen. Virol.
81: 2573-2604
[Full Text]
-
Allamand, V., Campbell, K. P.
(2000). Animal models for muscular dystrophy: valuable tools for the development of therapies. Hum Mol Genet
9: 2459-2467
[Abstract]
[Full Text]
-
Molinier-Frenkel, V., Gahery-Segard, H., Mehtali, M., Le Boulaire, C., Ribault, S., Boulanger, P., Tursz, T., Guillet, J.-G., Farace, F.
(2000). Immune Response to Recombinant Adenovirus in Humans: Capsid Components from Viral Input Are Targets for Vector-Specific Cytotoxic T Lymphocytes. J. Virol.
74: 7678-7682
[Abstract]
[Full Text]
-
Liu, Z.-X., Govindarajan, S., Okamoto, S., Dennert, G.
(2000). NK Cells Cause Liver Injury and Facilitate the Induction of T Cell-Mediated Immunity to a Viral Liver Infection. J. Immunol.
164: 6480-6486
[Abstract]
[Full Text]
-
Lozier, J. N., Metzger, M. E., Donahue, R. E., Morgan, R. A.
(1999). Adenovirus-Mediated Expression of Human Coagulation Factor IX in the Rhesus Macaque Is Associated With Dose-Limiting Toxicity. Blood
94: 3968-3975
[Abstract]
[Full Text]
-
Gorziglia, M. I., Lapcevich, C., Roy, S., Kang, Q., Kadan, M., Wu, V., Pechan, P., Kaleko, M.
(1999). Generation of an Adenovirus Vector Lacking E1, E2a, E3, and All of E4 except Open Reading Frame 3. J. Virol.
73: 6048-6055
[Abstract]
[Full Text]
-
Kaplan, J. M., Armentano, D., Scaria, A., Woodworth, L. A., Pennington, S. E., Wadsworth, S. C., Smith, A. E., Gregory, R. J.
(1999). Novel Role for E4 Region Genes in Protection of Adenovirus Vectors from Lysis by Cytotoxic T Lymphocytes. J. Virol.
73: 4489-4492
[Abstract]
[Full Text]
-
Stein, C. S., Ghodsi, A., Derksen, T., Davidson, B. L.
(1999). Systemic and Central Nervous System Correction of Lysosomal Storage in Mucopolysaccharidosis Type VII Mice. J. Virol.
73: 3424-3429
[Abstract]
[Full Text]
-
Moorhead, J. W., Clayton, G. H., Smith, R. L., Schaack, J.
(1999). A Replication-Incompetent Adenovirus Vector with the Preterminal Protein Gene Deleted Efficiently Transduces Mouse Ears. J. Virol.
73: 1046-1053
[Abstract]
[Full Text]
-
Jooss, K., Gjata, B., Danos, O., von Boehmer, H., Sarukhan, A.
(2001). Regulatory function of in vivo anergized CD4+ T cells. Proc. Natl. Acad. Sci. USA
98: 8738-8743
[Abstract]
[Full Text]
-
Qian, H. S., Channon, K., Neplioueva, V., Wang, Q., Finer, M., Tsui, L., George, S. E., McArthur, J.
(2001). Improved Adenoviral Vector for Vascular Gene Therapy : Beneficial Effects on Vascular Function and Inflammation. Circ. Res.
88: 911-917
[Abstract]
[Full Text]